Bayer shares fell after plaintiffs sought to transfer a proposed $7.25 billion U.S. settlement over Roundup weedkiller to a ...

From gene editing to herbicide-resistant plants, Bayer continues to stretch the limits of agriculture innovation. Chief ...

Bayer shares drop as Roundup settlement faces federal court shift, raising litigation risk and timeline doubts.

By Renee Hickman and Tom Polansek CHICAGO, June 2 (Reuters) - Bayer has no plans to spin off Monsanto, a representative said on Tuesday, even as the company faces an avalanche of lawsuits over its ...

Latham Quality, a north Iowa seed company, alleges in a lawsuit that Bayer has used anticompetitive practices to corner the ...

Opponents of Bayer AG’s $7.25 billion proposal in Missouri state court to settle thousands of US cancer lawsuits over its Roundup weedkiller are trying to get a federal judge in California who shares ...

A ​decade on, the German ⁠pharma giant is ​worth less than ​the $62 bln it paid for Roundup's maker. ​Known legal risks ...

Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company’s shares and piling pressure on its CEO to ...

Bayer has appealed a verdict awarding $1.25M to a man who was diagnosed with non-Hodgkin lymphoma after years of exposure to glyphosate in Roundup.

Bayer used illegal and anti-competitive practices to monopolize the U. market for genetically engineered corn seeds, reaping ...

Bayer AG (OTC:BAYRY) (OTC:BAYZF) will hold off on plans to break the group, the new CEO Bill Anderson said. On the question of the company’s structure and a possible break-up of the group, “our answer ...